NEW ENGLAND ASSET MANAGEMENT INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW ENGLAND ASSET MANAGEMENT INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$10,000
-99.0%
563
-99.0%
0.00%
-100.0%
Q4 2020$1,009,000
+2.0%
55,4260.0%0.02%
-16.7%
Q3 2020$989,000
+0.2%
55,426
+0.7%
0.02%0.0%
Q2 2020$987,000
+18.2%
55,0260.0%0.02%
+20.0%
Q1 2020$835,000
-21.1%
55,026
+2.6%
0.02%
+17.6%
Q4 2019$1,058,000
+14.8%
53,6260.0%0.02%0.0%
Q3 2019$922,000
-2.8%
53,6260.0%0.02%
-10.5%
Q2 2019$949,000
+19.7%
53,626
+37.7%
0.02%
+26.7%
Q1 2019$793,00038,9320.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders